BWLSA
Blue Water Life Science Advisors Portfolio holdings
AUM
$126M
This Quarter Return
-6.71%
1 Year Return
+132.45%
3 Year Return
+197.53%
5 Year Return
–
10 Year Return
–
AUM
$148M
AUM Growth
+$148M
(-2%)
Cap. Flow
+$9.12M
Cap. Flow
% of AUM
6.16%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
9
New
1
Increased
2
Reduced
1
Closed
2
Top Buys
| 1 |
AKYA
Akoya BioSciences
AKYA
|
$19.2M |
| 2 |
NSTG
NanoString Technologies, Inc.
NSTG
|
$11M |
| 3 |
Guardant Health
GH
|
$6.64M |
Top Sells
| 1 |
Bruker
BRKR
|
$11.4M |
| 2 |
Cytek Biosciences
CTKB
|
$10.2M |
| 3 |
MaxCyte
MXCT
|
$6.15M |
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Natera
NTRA
$23.1B
| $42.9M | 28.95% |
881,436
| – | – |
|
|
AKYA
2
DELISTED
Akoya BioSciences
AKYA
| $34.7M | 23.43% |
4,697,785
+2,600,000
| +124% | +$19.2M |
|
|
3
Guardant Health
GH
$8.41B
| $24.2M | 16.34% |
676,047
+185,602
| +38% | +$6.64M |
|
4
Adaptive Biotechnologies
ADPT
$2.01B
| $20.3M | 13.72% |
3,030,434
| – | – |
|
|
NSTG
5
DELISTED
NanoString Technologies, Inc.
NSTG
| $11M | 7.45% |
+2,726,891
| New | +$11M |
|
|
6
MaxCyte
MXCT
$148M
| $8.65M | 5.84% |
1,885,000
-1,340,000
| -42% | -$6.15M |
|
|
SONX
7
DELISTED
Sonendo, Inc.
SONX
| $6.32M | 4.26% |
4,643,461
| – | – |
|
|
8
Bruker
BRKR
$5.16B
| – | – |
-145,100
| Closed | -$11.4M |
|
|
9
Cytek Biosciences
CTKB
$527M
| – | – |
-1,109,000
| Closed | -$10.2M |
|